Tests:CA 125: Difference between revisions
Tests:CA 125
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== Overview == | |||
|- | |- | ||
|Department | |Department | ||
| Line 15: | Line 16: | ||
|C125 | |C125 | ||
C-125 | C-125 | ||
C12-5 | C12-5 | ||
|- | |||
|Test Availability | |||
|Tuesday and Thursday | |||
Contact lab if testing is required urgently | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
| Line 24: | Line 30: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Specimen Requirements == | ||
|- | |- | ||
|Specimen Type | |Specimen Type | ||
|Serum | |Serum | ||
Plasma | Plasma | ||
|- | |||
|Specimen Transportation | |||
| | |||
|- | |- | ||
|Preferred | |Preferred | ||
|7mL <span style="background:#e30022"> Red-Top </span> | |7mL <span style="background:#e30022"> Red-Top </span> | ||
|- | |- | ||
|Acceptable | |Acceptable | ||
|SST <span style="background: #fbec5d"> Yellow-Top</span> | |SST <span style="background: #fbec5d"> Yellow-Top</span> | ||
|- | |- | ||
| | |Unacceptable | ||
| | | | ||
|- | |- | ||
| | |Paediatric Requirements | ||
|0.5 <span style="background:#e30022"> Red </span> microtainer | |0.5 <span style="background:#e30022"> Red </span> microtainer | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Aliquot Requirements == | ||
|- | |- | ||
|Sample Type | |Sample Type | ||
|>500 uL | |Serum | ||
|- | |||
|Preferred Volume | |||
|>500 uL | |||
|- | |- | ||
|Minimum Volume | |Minimum Volume | ||
|200 uL | |200 uL | ||
|- | |- | ||
|Aliquot Transportation | |Aliquot Transportation | ||
|Samples should be separated from red cells within 24hrs of collection. | |Samples should be separated from red cells within 24hrs of collection. | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== Clinical Information == | |||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 70: | Line 83: | ||
| | | | ||
|- | |- | ||
! colspan="2" | | |||
== Comments == | |||
|- | |- | ||
| colspan="2" | | | colspan="2" |Used for monitoring Ovarian Carcinoma. | ||
Used for monitoring Ovarian Carcinoma. | |||
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | ||
|} | |} | ||